Filing Details

Accession Number:
0001615774-17-005848
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-23 19:25:18
Reporting Period:
2017-10-19
Accepted Time:
2017-10-23 19:25:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1621443 Zynerba Pharmaceuticals Inc. ZYNE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405685 Michael Rapp 9701 Collins Avenue, #1902-S
Bal Harbor FL 33154
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-19 44,255 $9.59 1,398,370 No 4 P Direct
Common Stock Acquisiton 2017-10-20 30,000 $9.78 1,428,370 No 4 P Direct
Common Stock Acquisiton 2017-10-23 25,745 $9.94 1,454,115 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes 80,467 shares transferred by Broadband Capital Management LLC ("BCM") to Reporting Person for no consideration. The Reporting Person was the Chairman and member of BCM.